Acute myeloid leukemia (AML) is a complex disease caused by deregulation of multiple signaling pathways. Mutations in class III receptor tyrosine kinases (RTKs) have been implicated in alteration of cell signals concerning the growth and differentiation of leukemic cells. Point mutations, insertions, or deletions of RTKs as well as chromosomal translocations induce constitutive activation of the receptor, leading to uncontrolled proliferation of undifferentiated myeloid blasts. Aberrations can occur in all domains of RTKs causing either the ligand-independent activation or mimicking the activated conformation. The World Health Organization recommended including RTK mutations in the AML classification since their detection in routine laborat...
Background and purpose: Mutation of FMS like tyrosine kinase (flt3) gene causes uncontrolled prolife...
The efforts made in the last decade regarding the molecular landscape of acute myeloid leukemia (AML...
Acute myeloid leukaemia (AML) is a biologically complex, molecularly and clinically heterogeneous di...
FLT3 (fms-related tyrosine kinase 3) is a receptor tyrosine kinase class III that is expressed on by...
Acute Myeloid Leukaemia (AML) is a malignant blood cancer characterised by uncontrolled growth of le...
Background: The secondary genetic changes other than the promyelocytic leukemia-retinoic acid recept...
Among adults, acute myeloid leukemia (AML) is the second most frequent type of leukemia. In spite of...
Cytogenetic and molecular genetic analyses are necessary for precise assessment of diagnosis, progno...
Cytogenetic and molecular genetic analyses are necessary for precise assessment of diagnosis, progno...
Abstract Background and purpose: Mutation of FMS like tyrosine kinase (flt3) gene causes uncontrol...
Mutations in the fms-like tyrosine kinase 3 (FLT3) gene, such as internal tandem duplication (FLT3/I...
Mutations in the fms-like tyrosine kinase 3 (FLT3) gene, such as internal tandem duplication (FLT3/I...
The Fms-like tyrosine kinase-3 (FLT3) is a receptor tyrosine kinase that plays a key role in cell su...
FLT3, a receptor tyrosine kinase, is expressed in hematopoietic progenitor cells. FLT3-ITD (internal...
Summary Classification of acute myeloid leukemia increasingly depends on genetic analysis. However, ...
Background and purpose: Mutation of FMS like tyrosine kinase (flt3) gene causes uncontrolled prolife...
The efforts made in the last decade regarding the molecular landscape of acute myeloid leukemia (AML...
Acute myeloid leukaemia (AML) is a biologically complex, molecularly and clinically heterogeneous di...
FLT3 (fms-related tyrosine kinase 3) is a receptor tyrosine kinase class III that is expressed on by...
Acute Myeloid Leukaemia (AML) is a malignant blood cancer characterised by uncontrolled growth of le...
Background: The secondary genetic changes other than the promyelocytic leukemia-retinoic acid recept...
Among adults, acute myeloid leukemia (AML) is the second most frequent type of leukemia. In spite of...
Cytogenetic and molecular genetic analyses are necessary for precise assessment of diagnosis, progno...
Cytogenetic and molecular genetic analyses are necessary for precise assessment of diagnosis, progno...
Abstract Background and purpose: Mutation of FMS like tyrosine kinase (flt3) gene causes uncontrol...
Mutations in the fms-like tyrosine kinase 3 (FLT3) gene, such as internal tandem duplication (FLT3/I...
Mutations in the fms-like tyrosine kinase 3 (FLT3) gene, such as internal tandem duplication (FLT3/I...
The Fms-like tyrosine kinase-3 (FLT3) is a receptor tyrosine kinase that plays a key role in cell su...
FLT3, a receptor tyrosine kinase, is expressed in hematopoietic progenitor cells. FLT3-ITD (internal...
Summary Classification of acute myeloid leukemia increasingly depends on genetic analysis. However, ...
Background and purpose: Mutation of FMS like tyrosine kinase (flt3) gene causes uncontrolled prolife...
The efforts made in the last decade regarding the molecular landscape of acute myeloid leukemia (AML...
Acute myeloid leukaemia (AML) is a biologically complex, molecularly and clinically heterogeneous di...